home / stock / ausaf / ausaf news


AUSAF News and Press, Australis Capital Inc From 03/24/21

Stock Information

Company Name: Australis Capital Inc
Stock Symbol: AUSAF
Market: OTC
Website: ausa-corp.com

Menu

AUSAF AUSAF Quote AUSAF Short AUSAF News AUSAF Articles AUSAF Message Board
Get AUSAF Alerts

News, Short Squeeze, Breakout and More Instantly...

AUSAF - Australis completes stage one of Green Therapeutics acquisition

Australis Capital ([[AUSAF]] -0.6%) completes the first stage of the transaction to acquire Green Therapeutics.The transaction to complete in two parts, the first, now closed, being the acquisition of a subsidiary of GT( containing a number of unregulated assets including the GT bra...

AUSAF - Australis Completes First Stage in Green Therapeutics LLC Acquisition

Australis Completes First Stage in Green Therapeutics LLC Acquisition PR Newswire Transaction Marks Company's Transition to Being a Cannabis Industry Operator Accretive Transaction Adds High-Margin Revenues and Award-Winning Brands Foundationa...

AUSAF - AUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC

AUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC PR Newswire Accretive Transaction Adds High-Margin Revenues and Award-Winning Brands Foundational Asset in AUSA's Multi-State Footprint Acquisition Agreement Includes R...

AUSAF - Australis Completes Acquisition of 51% Interest in ALPS

Australis Completes Acquisition of 51% Interest in ALPS PR Newswire Terry Booth Appointed CEO, Dr. Duke Fu Appointed COO LAS VEGAS , March 9, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced...

AUSAF - Australis' Accretive Acquisitions (Podcast Transcript)

Australis Capital CFO Jon Paul joins the show to discuss closing its acquisitions and why coming on board was a bet on CEO Terry Booth. How MSOs will rationalize over time; optimism on banking opening up. IPOs, SPACs, and why the FDA needs to provide more certainty on CBD. F...

AUSAF - Australis' Accretive Acquisitions (Podcast)

Australis Capital CFO Jon Paul joins the show to discuss closing its acquisitions and why coming on board was a bet on CEO Terry Booth. How MSOs will rationalize over time; optimism on banking opening up. IPOs, SPACs, and why the FDA needs to provide more certainty on CBD. F...

AUSAF - Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture

Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture Canada NewsWire JV Focused on Commercialization of IP for Commercial Scale Tissue Culture for Cannabis, Hemp and Traditional Crops JV Also Provides Access to other Commercial Ready, Breakthr...

AUSAF - Australis Q3 2021 Conference Call

Australis Q3 2021 Conference Call PR Newswire Management Will Host Conference Call Tuesday March 2, 2021 at 10am ET LAS VEGAS , March 2, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") is hosting a con...

AUSAF - Australis Capital reports Q3 results

Australis Capital (AUSAF): Q3 net loss of $19.4MRevenue of $0.09MPress Release For further details see: Australis Capital reports Q3 results

AUSAF - Australis Reports Q3 2021 Results

Australis Reports Q3 2021 Results Canada NewsWire Results Impacted by Non-Cash Impairments and Reserve Adjustments Related to Legacy Business Company positioned for rapid growth upon completion of ALPS and Green Therapeutics transactions Conference Call...

Previous 10 Next 10